BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu H, Zhao W, Zhang J, Han J, Liu S. Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma. BMC Gastroenterol 2018;18:174. [PMID: 30419830 DOI: 10.1186/s12876-018-0899-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Beppu T, Yamamura K, Okabe H, Imai K, Hayashi H. Oncological benefits of portal vein embolization for patients with hepatocellular carcinoma. Ann Gastroenterol Surg 2021;5:287-95. [PMID: 34095718 DOI: 10.1002/ags3.12414] [Reference Citation Analysis]
2 Ba H, Xu L, Peng H, Lin Y, Li X, Qin Y, Wang H. Beta Blocker Therapy for Congenital Hepatic Arteriovenous Fistula in Two Neonates. Front Pediatr 2020;8:163. [PMID: 32373560 DOI: 10.3389/fped.2020.00163] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Sun T, Ren Y, Kan X, Chen L, Zhang W, Yang F, Zheng C. Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With Apatinib. Front Mol Biosci 2020;7:607520. [PMID: 33344507 DOI: 10.3389/fmolb.2020.607520] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Takahashi H, Mori K, Sekino Y, Okumura T, Hiyama T, Fukuda K, Hasegawa N, Sakai M, Kikuchi S, Takei Y, Iizumi T, Sakurai H, Minami M. Angiographic Findings in Patients with Hepatocellular Carcinoma Previously Treated Using Proton Beam Therapy. J Oncol 2019;2019:3580379. [PMID: 31354819 DOI: 10.1155/2019/3580379] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]